| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0021055> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0024262> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0034790> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0039194> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C0282580> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34424997_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Immatics N.V., Tübingen, Germany.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies,\', University of Tübingen, Tübingen, Germany.\', \'NGS Competence Center Tübingen, Tübingen, Germany.\', \'Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.\', \'Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bilich_Tatjana> <https://research.tib.eu/covid-19/entity/Brunk_Fabian> <https://research.tib.eu/covid-19/entity/Casadei_Nicolas> <https://research.tib.eu/covid-19/entity/Fraschka_Sabine_A_K> <https://research.tib.eu/covid-19/entity/H%C3%B6rber_Sebastian> <https://research.tib.eu/covid-19/entity/Heitmann_Jonas_S> <https://research.tib.eu/covid-19/entity/Maurer_Dominik> <https://research.tib.eu/covid-19/entity/Moritz_Andreas> <https://research.tib.eu/covid-19/entity/Nelde_Annika> <https://research.tib.eu/covid-19/entity/Peter_Andreas> <https://research.tib.eu/covid-19/entity/Rammensee_Hans-Georg> <https://research.tib.eu/covid-19/entity/Singh_Harpreet> <https://research.tib.eu/covid-19/entity/Wagner_Claudia> <https://research.tib.eu/covid-19/entity/Walz_Juliane>
?:doi	10.1002/eji.202149290
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/eji.202149290>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	European journal of immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34424997>
?:pmid	<https://research.tib.eu/covid-19/entity/34424997>
?:pmid	34424997
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.206
?:rankingScore_hIndex	185
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0009013_LOCATION_OF_C0034790> <https://research.tib.eu/covid-19/entity/C0030705_LOCATION_OF_C0034790>
?:title	SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Immatics N.V., Tübingen, Germany.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies,\', University of Tübingen, Tübingen, Germany.\', \'NGS Competence Center Tübingen, Tübingen, Germany.\', \'Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.\', \'Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.\']

?:citedBy